Systematic variations associated with renal disease uncovered by parallel metabolomics of urine and serum

BMC Systems Biology

Volumn 6, Issue SUPPL.1, 2012, Pages

  Gao, Xianfu ^a   Chen, Wanjia ^b   Li, Rongxia ^a   Wang, Minfeng ^a   Chen, Chunlei ^a   Zeng, Rong ^a   Deng, Yueyi ^b  

^a Chinese Academy of Sciences   (China)

^b LONGHUA HOSPITAL AFFILIATED TO SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD; BLOOD ANALYSIS; HUMAN; MASS FRAGMENTOGRAPHY; MEMBRANOUS GLOMERULONEPHRITIS; METABOLISM; METABOLOMICS; METHODOLOGY; PATHOLOGY; SYSTEMS BIOLOGY; URINALYSIS; URINE;

BLOOD CHEMICAL ANALYSIS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; METABOLOMICS; SYSTEMS BIOLOGY; URINALYSIS;

EID: 84875807390     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-6-S1-S14     Document Type: Article

References (36)

1. Ponticelli C. Membranous nephropathy. J Nephrol 2007, 20:268-287.
2. Cybulsky AV. Membranous nephropathy: From mechanisms to therapies. Dial Transplant 2010, 39:484-488.
3. Glassock RJ. The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey. Am J Kidney Dis 2010, 56:157-167. 10.1053/j.ajkd.2010.01.008, 20378220.
4. Hewitt SM, Dear J, Star RA. Discovery of protein biomarkers for renal diseases. J Am Soc Nephrol 2004, 15:1677-1689. 10.1097/01.ASN.0000129114.92265.32, 15213255.
5. Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29:1181-1189. 10.1080/004982599238047, 10598751.
6. Xie G, Zheng X, Qi X, Cao Y, Chi Y, Su M, Ni Y, Qiu Y, Liu Y, Li H, Zhao A, Jia W. Metabonomic evaluation of melamine-induced acute renal toxicity in rats. J Proteome Res 2010, 9:125-133. 10.1021/pr900333h, 19476335.
7. Taylor SL, Ganti S, Bukanov NO, Chapman A, Fiehn O, Osier M, Kim K, Weiss RH. A metabolomics approach using juvenile cystic mice to identify urinary biomarkers and altered pathways in polycystic kidney disease. Am J Physiol Renal Physiol 2010, 298:F909-F922. 10.1152/ajprenal.00722.2009, 2853321, 20130118.
8. Kim K, Taylor SL, Ganti S, Guo L, Osier MV, Weiss RH. Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer. OMICS 2011, 15:293-303. 10.1089/omi.2010.0094, 3125558, 21348635.
9. Boudonck KJ, Mitchell MW, Német L, Keresztes L, Nyska A, Shinar D, Rosenstock M. Discovery of metabolomics biomarkers for early detection of nephrotoxicity. Toxicol Pathol 2009, 37:280-292. 10.1177/0192623309332992, 19380839.
10. Lewis GD, Asnani A, Gerszten RE. Application of metabolomics to cardiovascular biomarker and pathway discovery. J Am Coll Cardiol 2008, 52:117-123. 10.1016/j.jacc.2008.03.043, 3204897, 18598890.
11. Lenz EM, Wilson ID. Analytical Strategies in Metabonomics. J Proteome Res 2007, 6:443-458. 10.1021/pr0605217, 17269702.
12. Gao X, Pujos-Guillot E, Martin J-F, Galan P, Juste C, Jia W, Sebedio J-L. Metabolite analysis of human fecal water by gas chromatography/mass spectrometry with ethyl chloroformate derivatization. Anal Biochem 2009, 393:163-175. 10.1016/j.ab.2009.06.036, 19573517.
13. Pereira H, Martin J-F, Joly C, Sébédio J-L, Pujos-Guillot E. Development and validation of a UPLC/MS method for a nutritional metabolomic study of human plasma. Metabolomics 2010, 6:207-218.
14. Parab GS, Rao R, Lakshminarayanan S, Bing YV, Moochhala SM, Swarup S. Data-driven optimization of metabolomics methods using rat liver samples. Anal Chem 2009, 81:1315-1323. 10.1021/ac801645t, 19140735.
15. Antonucci R, Atzori L, Barberini L, Fanos V. Metabolomics: the "new clinical chemistry" for personalized neonatal medicine. Minerva Pediatr 2010, 62(3 Suppl 1):145-148.
16. Kind T, Tolstikov V, Fiehn O, Weiss RH. A comprehensive urinary metabolomic approach for identifying kidney cancer. Anal Biochem 2007, 363:185-195. 10.1016/j.ab.2007.01.028, 17316536.
17. Ngai HH, Sit WH, Jiang PP, Xu RJ, Wan JM, Thongboonkerd V. Serial changes in urinary proteome profile of membranous nephropathy: implications for pathophysiology and biomarker discovery. J Proteome Res 2006, 5:3038-3047. 10.1021/pr060122b, 17081055.
18. Gika HG, Macpherson E, Theodoridis GA, Wilson ID. Evaluation of the repeatability of ultra-performance liquid chromatography-TOF-MS for global metabolic profiling of human urine samples. J Chromatogr B Analyt Technol Biomed Life Sci 2008, 871:299-305. 10.1016/j.jchromb.2008.05.048, 18579458.
19. den Hartog GJ, Boots AW, Adam-Perrot A, Brouns F, Verkooijen IW, Weseler AR, Haenen GR, Bast A. Erythritol is a sweet antioxidant. Nutrition 2010, 26:449-458. 10.1016/j.nut.2009.05.004, 19632091.
20. Yokozawa T, Kim HY, Cho EJ. Erythritol attenuates the diabetic oxidative stress through modulating glucose metabolism and lipid peroxidation in streptozotocin-induced diabetic rats. J Agric Food Chem 2002, 50:5485-5489. 10.1021/jf020168z, 12207496.
21. Nangaku M, Shankland SJ, Couser WG. Cellular response to injury in membranous nephropathy. J Am Soc Nephrol 2005, 16:1195-1204. 10.1681/ASN.2004121098, 15800119.
22. Bergseth S, Hokland BM, Bremer J. Metabolism of dicarboxylic acids in vivo and in the perfused kidney of the rat. Biochim Biophys Acta 1988, 961:103-109. 10.1016/0005-2760(88)90135-X, 3132982.
23. de Oliveira Marques F, Hagen ME, Pederzolli CD, Sgaravatti AM, Durigon K, Testa CG, Wannmacher CMD, de Souza Wyse AT, Wajner M, Dutra-Filho CS. Glutaric acid induces oxidative stress in brain of young rats. Brain Res 2003, 964:153-158. 10.1016/S0006-8993(02)04118-5, 12573524.
24. Passi S, Picardo M, De Luca C, Nazzaro-Porro M, Rossi L, Rotilio G. Saturated dicarboxylic acids as products of unsaturated fatty acid oxidation. Biochim Biophys Acta 1993, 1168:190-198. 10.1016/0005-2760(93)90124-R, 8504154.
25. Thomas M, Hughes RE. A relationship between ascorbic acid and threonic acid in guinea-pigs. Food Chem Toxicol 1983, 21:449-452. 10.1016/0278-6915(83)90101-1, 6684626.
26. Satriano J, Schwartz D, Ishizuka S, Lortie MJ, Thomson SC, Gabbai F, Kelly CJ, Blantz RC. Suppression of inducible nitric oxide generation by agmatine aldehyde: Beneficial effects in sepsis. J Cell Physiol 2001, 188:313-320. 10.1002/jcp.1119, 11473357.
27. Braun N, Frank J, Biesalski HK, Risler T. Antioxidative treatment retards progression of idiopathic membranous nephropathy. Nephron 2000, 86:208-209. 10.1159/000045751, 11015002.
28. Chen ZH, Qin WS, Zeng CH, Zheng CX, Hong YM, Lu YZ, Li LS, Liu ZH. Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro. Kidney Int 2010, 77:974-988. 10.1038/ki.2010.41, 20375980.
29. Ranjith NK, Sasikala C, Ramana CV. Catabolism of L-phenylalanine and L-tyrosine by Rhodobacter sphaeroides OU5 occurs through 3,4-dihydroxyphenylalanine. Res Microbiol 2007, 158:506-511. 10.1016/j.resmic.2007.04.008, 17616348.
30. Raneva V, Shimasaki H, Ishida Y, Ueta N, Niki E. Antioxidative activity of 3,4-dihydroxyphenylacetic acid and caffeic acid in rat plasma. Lipids 2001, 36:1111-1116. 10.1007/s11745-001-0821-6, 11768155.
31. Levchuk AA, Faron RA, Khrustalev SA, Raushenbakh MO. Effect of the carcinogenic tyrosine metabolite p-hydroxyphenyllactic acid on the ascorbic acid concentration in the organs and blood of mice. Biull Eksp Biol Med 1986, 102:462-463. 10.1007/BF00851066, 3768514.
32. Leipnitz G, Schumacher C, Scussiato K, Dalcin KB, Wannmacher CM, Wyse AT, Dutra-Filho CS, Wajner M, Latini A. Quinolinic acid reduces the antioxidant defenses in cerebral cortex of young rats. Int J Dev Neurosci 2005, 23:695-701. 10.1016/j.ijdevneu.2005.08.004, 16213122.
33. Rodríuez-Martíez E, Camacho A, Maldonado PD, Pedraza-Chaverr J, Santamarí D, Galvá-Arzate S, Santamarí A. Effect of quinolinic acid on endogenous antioxidants in rat corpus striatum. Brain Res 2000, 858:436-439. 10.1016/S0006-8993(99)02474-9, 10708698.
34. Yoshimura H, Sakai T, Kuwahara Y, Ito M, Tsuritani K, Hirasawa Y, Nagamatsu T. Effects of kynurenine metabolites on mesangial cell proliferation and gene expression. Exp Mol Pathol 2009, 87:70-75. 10.1016/j.yexmp.2009.02.002, 19268458.
35. Gao X, Pujos-Guillot E, Sébédio J-L. Development of a quantitative metabolomic approach to study clinical human fecal water metabolome based on trimethylsilylation derivatization and GC/MS analysis. Anal Chem 2010, 82:6447-6456. 10.1021/ac1006552, 20669995.
36. Holmes E, Loo RL, Stamler J, Bictash M, Yap IK, Chan Q, Ebbels T, De Iorio M, Brown IJ, Veselkov KA, Daviglus ML, Kesteloot H, Ueshima H, Zhao L, Nicholson JK, Elliott P. Human metabolic phenotype diversity and its association with diet and bloodpressure. Nature 2008, 453:396-400. 10.1038/nature06882, 18425110.